GE HealthCare Technologies Inc. (GEHC) – What Are Analysts Thinking About This Stock?

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twenty-three research firms that are covering the firm, Marketbeat.com reports. Eleven research analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $82.17.

A number of brokerages have recently commented on GEHC. Wall Street Zen raised GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, October 31st. UBS Group increased their price target on shares of GE HealthCare Technologies from $73.00 to $80.00 and gave the company a “neutral” rating in a research report on Tuesday, November 3rd. Bank of America reissued a “neutral” rating on shares of GE HealthCare Technologies in a research note on Thursday, October 29th. Royal Bank Of Canada boosted their price objective on shares of GE HealthCare Technologies from $80.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, October 29th. Finally, Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $75.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, July 30th.

View Our Latest Stock Analysis on GE HealthCare Technologies

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors and hedge funds have recently made changes to their positions in GEHC. NBH Bank acquired a new position in GE HealthCare Technologies in the second quarter valued at about $26,000. First Eagle Investment Management LLC increased its holdings in shares of GE HealthCare Technologies by 77.6% in the third quarter. First Eagle Investment Management LLC now owns 437 shares of the company’s stock worth $29,000 after acquiring an additional 191 shares in the last quarter. Provenance Wealth Advisors LLC raised its position in shares of GE HealthCare Technologies by 401.0% during the third quarter. Provenance Wealth Advisors LLC now owns 491 shares of the company’s stock worth $32,000 after purchasing an additional 393 shares during the period. Global Assets Advisory LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth about $37,000. Finally, Fortitude Family Office LLC lifted its holdings in shares of GE HealthCare Technologies by 249.1% during the 3rd quarter. Fortitude Family Office LLC now owns 597 shares of the company’s stock valued at $39,000 after purchasing an additional 426 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $83.02 on Monday. The business has a fifty day simple moving average of $70.55 and a 200 day simple moving average of $70.11. The stock has a market cap of $37.54 billion, a PE ratio of 17.51, a price-to-earnings-growth ratio of 2.09 and a beta of 0.64. The company has a quick ratio of 1.01, a current ratio of 1.30 and a debt-to-equity ratio of 0.86. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.20 by $0.14. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. The firm had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.35 billion. During the same quarter in the prior year, the firm posted $1.07 earnings per share. The company’s quarterly revenue was up 7.2% on a year-over-year basis. Research analysts predict that GE HealthCare Technologies will post 5.02 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 13th. Stockholders of record on Friday, October 23rd were given a dividend of $0.04 per share. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.0350. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Friday, October 23rd. GE HealthCare Technologies’s payout ratio is 3.38%.

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Further Reading

Analyst Recommendations for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.